Is Furosemide Injection (Hydralazine Hydrochloride) in shortage?
Yes. Furosemide Injection is on FDA’s drug shortage list (unavailable), last updated Oct 6, 2026.
Why it’s in shortage
- Demand increase for the drug
- Discontinuation of the manufacture of the drug
- Other
- Requirements related to complying with good manufacturing practices
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-02)
Check wholesalers for inventory
Maker contact: 888-386-1300
- Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-04)
Check wholesalers for inventory
Maker contact: 888-386-1300
- Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-10)
Check wholesalers for inventory
Maker contact: 888-386-1300
- Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-41)
Maker contact: 855-228-9470
- Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-42)
Maker contact: 855-228-9470
- Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-44)
Estimated recovery: End October 2026; Capacity constraint
Maker contact: 855-228-9470
- Furosemide, Injection, 10 mg/1 mL (NDC 16729-500-08)
Estimated recovery: TBD/ NDC non-Exempt
Maker contact: 866-941-7875
- Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43)
Estimated recovery: TBD/ NDC non-Exempt
Maker contact: 866-941-7875
- Furosemide, Injection, 10 mg/1 mL (NDC 16729-502-43)
Estimated recovery: TBD/ NDC non-Exempt
Maker contact: 866-941-7875
- Furosemide, Injection, 10 mg/1 mL (NDC 36000-282-25)
Maker contact: 888-229-0001
- Furosemide, Injection, 10 mg/1 mL (NDC 36000-283-25)
Maker contact: 888-229-0001
- Furosemide, Injection, 10 mg/1 mL (NDC 36000-284-25)
Maker contact: 888-229-0001
- Furosemide, Injection, 20 mg/2 mL (NDC 55150-322-25)
On backorder. Recovery: TBD. Check wholesalers for inventory
Maker contact: 888-238-7880
- Furosemide, Injection, 40 mg/4 mL (NDC 55150-323-25)
Check wholesalers for inventory
Maker contact: 888-238-7880
- Furosemide, Injection, 100 mg/10 mL (NDC 55150-324-25)
Check wholesalers for inventory
Maker contact: 888-238-7880
- Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-02)
Maker contact: 844-646-4398
- Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-04)
Maker contact: 844-646-4398
- Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-10)
Maker contact: 844-646-4398
- Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-25)
Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-26)
Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-27)
Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-05)
Check wholesalers for inventory
Maker contact: 844-824-8426
- Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-11)
Check wholesalers for inventory
Maker contact: 844-824-8426
- Furosemide, Injection, 10 mg/mL, 2 mL (NDC 71288-205-03)
Check wholesalers for inventory
Maker contact: 844-824-8426
- Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02)
Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product More from the maker
Maker contact: 866-625-1618
- Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04)
Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product More from the maker
Maker contact: 866-625-1618
- Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10)
Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product More from the maker
Maker contact: 866-625-1918
FDA recalls of the same active ingredient
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Furosemide Injection:
- Leading Pharma, LLC recalls Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ
- Graviti Pharmaceuticals Private Limited recalls Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick,
- CARDINAL HEALTHCARE recalls HydrALAZINE Hydrochloride Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Distributed by: Avet Pharmaceuticals
- Mckesson Medical Surgical recalls hydrALAZINE HYDROCHLORIDE INJECTION, USP, 20 mg/mL, 1 mL Single Dose Vial, packaged in 25 Vials per carton, Rx only,
- Roxane Laboratories, Inc. recalls Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC
- Boehringer Ingelheim Roxane Inc recalls FUROSEMIDE Tablets USP, 40 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane
- Boehringer Ingelheim Roxane Inc recalls FUROSEMIDE Tablets USP, 20 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane
- Fresenius Kabi USA, LLC recalls Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL fill, in a 2 mL; single dose vial. Manufactured by Fresenius
- Hospira Inc. recalls Furosemide Injection, USP, 40 mg/4mL (10 mg/mL), 4 ml Single-Dose Vial, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045
- Hospira, Inc. recalls Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDC
Other forms on FDA’s list
Furosemide Injection shortage questions
Is Furosemide Injection (Hydralazine Hydrochloride) in shortage?
Yes. Furosemide Injection is on FDA’s drug shortage list (unavailable), last updated Oct 6, 2026.
Why is there a Furosemide Injection shortage?
FDA records the reason as: Demand increase for the drug; Discontinuation of the manufacture of the drug; Other; Requirements related to complying with good manufacturing practices.
What should I do if I can’t get Furosemide Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.